Bekker, P., Keshav, S., Wei, Z., Ertl, L., Wang, Y., Lai, N., Wright, J., Ungashe, S., & Schall, T. (2016). Pharmacological inhibition of CCR9 is a novel approach in the treatment of inflammatory bowel disease. INFLAMMATION RESEARCH, 56, S350–S350.

Bekker, P., et al. “Pharmacological Inhibition of CCR9 Is a Novel Approach in the Treatment of Inflammatory Bowel Disease.” INFLAMMATION RESEARCH, vol. 56, 2016, pp. S350–S350.

Bekker, P, S Keshav, Z Wei, L Ertl, Y Wang, N Lai, J Wright, S Ungashe, and T Schall. 2016. “Pharmacological Inhibition of CCR9 Is a Novel Approach in the Treatment of Inflammatory Bowel Disease.” INFLAMMATION RESEARCH 56: S350–S350.